Medicare Enrolled

Dr. Philippe Desplat, D.O.

Family Medicine · Dumont, NJ
Low-engagement
40 WASHINGTON AVE, Dumont, NJ 07628
2013877055
In practice since 2006 (20 years)
NPI: 1033166798 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desplat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desplat? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Desplat

Dr. Philippe Desplat is a family medicine specialist in Dumont, NJ, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Desplat received a total of $4,092 from 19 pharmaceutical and/or device companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Desplat is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $4,092 industry payments

Industry Payment Transparency

Open Payments through 2021 ↗
$4,092
Total received (2018-2021)
Avg $1,023/year across 4 years
Top 13% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
303
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,092 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$748
2020
$1,254
2019
$946
2018
$1,144

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$213
AstraZeneca Pharmaceuticals LP
$96
PFIZER INC.
$70
Lilly USA, LLC
$64
AbbVie Inc.
$57
Kowa Pharmaceuticals America, Inc.
$56
Merck Sharp & Dohme Corporation
$45
SANOFI-AVENTIS U.S. LLC
$40
Amarin Pharma Inc.
$37
Janssen Pharmaceuticals, Inc
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Amgen Inc.
$13
Genentech USA, Inc.
$13
GlaxoSmithKline, LLC.
$12
Top 3 companies account for 50.7% of 2021 payments
All-time payments by company (2018-2021) ›
Novo Nordisk Inc
$842
AstraZeneca Pharmaceuticals LP
$667
Lilly USA, LLC
$446
Merck Sharp & Dohme Corporation
$352
Boehringer Ingelheim Pharmaceuticals, Inc.
$304
PFIZER INC.
$242
GlaxoSmithKline, LLC.
$224
Amgen Inc.
$170
Janssen Pharmaceuticals, Inc
$166
SANOFI PASTEUR INC.
$156
SANOFI-AVENTIS U.S. LLC
$122
Kowa Pharmaceuticals America, Inc.
$103
Amarin Pharma Inc.
$92
Allergan, Inc.
$61
AbbVie Inc.
$57
Genentech USA, Inc.
$49
Circassia Pharmaceuticals Inc
$14
Sanofi Pasteur Inc.
$13
Horizon Therapeutics plc
$13
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
ADACEL · ANORO · ANORO ELLIPTA · ASMANEX · Aimovig · BELSOMRA · BEXSERO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · DUAKLIR PRESSAIR · DUEXIS · ELIQUIS · EMGALITY · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · INVOKANA · JANUVIA · JARDIANCE · Livalo · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · RYBELSUS · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VRAYLAR · Vascepa · Victoza · XARELTO · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Dumont?
Compare family medicine physicians in the Dumont area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,931
Per 100K population
307.0
County median income
$123,715
Nearest hospital
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2021
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Desplat is a family medicine specialist, with low-engagement industry engagement in the top 13% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Desplat receive payments from pharmaceutical companies?
Yes. Dr. Desplat received a total of $4,092 from 19 companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Desplat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →